小细胞肺癌化疗药物

Small cell lung cancer chemotherapy drugs

以上为机器翻译结果，快速获取精准的人工翻译结果，建议选择有道人工翻译

1
结论：艾易舒注射液能够缓解晚期非小细胞肺癌患者临床症状，改善生存质量，与化疗合用能够减轻化疗药物的毒副反应。
Conclusion: Aiyishu injection could alleviate the symptoms, improve the quality of life in the advanced NSCLC patients. Aiyishu injection could reduce the toxicity of chemotherapy.
2
方法：应用MTT显色分析法测定40例非小细胞肺癌实体瘤标本对9种化疗药物及其组成的联合化疗方案的敏感性或耐药性，并比较结果。
Methods: the drug sensitivity or resistance of 40 NSCLC samples to 9 chemotherapeutic drugs and combined chemotherapy were detected by MTT colorimetric assay, and compared the results.
3
本研究旨在观察mthfr基因C677T、A 1298c多态与非小细胞肺癌(NSCLC)患者对铂类药物为基础的化疗方案敏感性的关系。
The aim of this study is to investigate the relationship between genetic polymorphisms of MTHFR C677T or A1298C and the response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC).

点击反馈